PubMed.ai
PubMed.ai is a free AI search engine for the open-access biomedical literature indexed in PubMed. It summarizes the most relevant papers, lets you chat with them, and emails a structured research report. Academic reference only, never clinical use.
What is PubMed.ai?
PubMed.ai is an AI-assisted search engine for biomedical literature, built by what its About page calls an independent team of researchers and engineers. It works on the open-access literature indexed in PubMed: more than 40 million articles drawn from over 4,000 journals, covering medicine, biology, public health and the life sciences, with the index refreshed daily.
The mechanics sit closer to retrieval than to conversation. A query is first stripped of stop words such as what, is and are, then mapped onto aligned MeSH (Medical Subject Headings) terms, the vocabulary PubMed itself uses to index papers, and crossed with a keyword search over titles and abstracts. Large language models fine-tuned on the biomedical domain, combined with a reasoning step, then extract, summarize and interpret what the retrieved papers say.
Three blocks sit on top of that pipeline. Search returns a Result Summary that answers a question-shaped query by combining the findings of the twenty most relevant papers, alongside a Search Co-Pilot that writes an Introduction, Key Insights and a Conclusion, each element linking back to the corresponding PubMed record. Deep Chat is a per-query assistant grounded in those same twenty papers, with sample questions to get started. Search Report produces a full academic document, from Abstract, Introduction, Research Methods and Research Results through to Conclusion and References, delivered by email as a PDF and a Word file together with an .xlsx reference list; citations are formatted in APA with source links, PMID, authors, year and DOI.
The positioning is explicit: this is a search engine, not a general-purpose chatbot. Access is genuinely open, since the search page answers without an account and without payment, and the home page advertises laboratory protocols and literature reviews as coming soon. A thematic report, 2025 Medical Research Frontiers and Trends, is published as a free download.
The usage frame is stated just as plainly. A banner on every page reads that all content is provided for research purposes only and is not intended for clinical use in any way, and the articles repeat that the output is academic reference material, not medical advice, diagnosis or treatment.
What it does
- Search the open-access biomedical literature indexed in PubMed, with your query expanded into aligned MeSH terms
- Get an automatic summary of the twenty most relevant papers, and a direct answer when the query is phrased as a question
- Read a Search Co-Pilot brief with Introduction, Key Insights and Conclusion, each point traceable back to its source paper
- Ask free-form questions about the retrieved papers in Deep Chat
- Generate a structured research report in PDF and Word, delivered by email with an .xlsx reference list
- Sort and filter the literature list by publication date, year, article type and discipline
- Export citations in four styles and copy them in one click, with PMID, authors, year and DOI
When to use PubMed.ai / When not to
A quick filter to help you decide if PubMed.ai is the right fit.
When to use PubMed.ai
- Medical students who need a fast, sourced literature review for an assignment, a synthesis paper or a course reading list
- Researchers and scientists preparing systematic reviews, project proposals or research notes, and exporting formatted bibliographies as they go
- Clinicians building an evidence-based overview of what the published literature says, outside any patient-facing decision
- Pharmaceutical professionals compiling drug research reports and internal documentation from peer-reviewed sources
- Lecturers and teachers turning recent papers into teaching material and student-facing summaries
When not to use PubMed.ai
- Clinicians looking for bedside decision support: every page states the content is provided for research purposes only and is not intended for clinical use in any way
- Anyone seeking medical advice, a diagnosis or a treatment plan, for themselves or for a patient
- Researchers who need paywalled journals: the index covers the open-access literature in PubMed, so subscription-only papers fall outside the scope
- Users working outside the biomedical field, since the corpus is limited to medicine, biology, public health and the life sciences
- People expecting a general-purpose conversational assistant: the site positions itself as a search engine rather than a chatbot, and Deep Chat only answers from the twenty papers it retrieved
How to use PubMed.ai
A typical end-to-end flow, from setup to results.
- Open the search page from pubmed.ai, or use the search bar on the home page; no account is required
- Type a question or keywords, starting broad with a term such as cancer or diabetes, then refine
- Favor proper nouns, which the site recommends: diseases, drugs and medical conditions rather than vague phrasing
- Prefer a structured query such as "Effects of physical exercise on cardiovascular health in patients with hypertension" over "What are the effects of exercise on health?"
- Add a literature type, a year or a discipline inside the query itself to filter, as in "Metformin use in type 2 diabetes case reports" or "Cancer immunotherapy research 2025"
- Compare two concepts by linking them with and or vs, as in "apoptosis vs necrosis"
- Read the Result Summary first, then the AI Research Co-Pilot, then the Literature List
- Follow the Key Insights links through to the matching PubMed records to check the evidence yourself
- Open Deep Chat to question the retrieved papers, and copy citations in one click in any of the four available styles
- Click Download or Get Report to generate the full research report; the zipped folder arrives by email. For the API, request access through the contact form
Pros & Cons
Pros
- Free to use, with no paywall observed anywhere on the site and no pricing page to reckon with
- No account needed to run a search: the search page answers straight away
- Traceability, which is the real argument here: every Co-Pilot insight links back to the PubMed record it came from
- Broad scope and a live index: more than 40 million articles from over 4,000 journals, refreshed daily
- MeSH alignment, which matches the indexing logic PubMed uses natively rather than working around it
- Usable output: PDF plus an editable Word file, an .xlsx reference list, and APA citations carrying PMID and DOI
- Medical disclaimers and the intended usage frame are displayed without ambiguity, and the beta API is open free of charge for two months on request
Cons
- No terms of service and no privacy policy: the contractual void is total, on a service that collects email addresses
- No GDPR mention, no Article 27 representative, no data processing agreement, no sub-processor list, and nothing on where data is hosted or how long it is kept
- No legal entity, no postal address, no declared country of establishment: the team is presented as independent, and the section headed "Meet the Team Behind PubMed.ai" names nobody
- Coverage limited to open-access literature, so subscription-only papers are out of scope
- Deep Chat is bounded by the twenty retrieved papers, so a genuinely new question can go unanswered
- Broken links: the Product navigation item returns a 404, as do service.pubmed.ai and service.pubmed.ai/docs, both cited in the API article and both dead on 18 August 2026
- No mobile app, no browser extension, no stated minimum age, and reports that transit by email
Pricing & Plans
PubMed.ai is free of charge. The site publishes no pricing page: none exists today, none appears in the 69-URL sitemap and none is found in the Wayback archive, and no amount, currency or tier is quoted anywhere, so there is no lowest price point to report. The search page answers without an account or payment, the calls to action read Try For Free and Download for Free, the full research report is announced as free on the results page, and Deep Chat is advertised as unlimited. The beta API is offered as a free two-month test program, granted on request through the contact form. No commitment to remain free is written anywhere, so this should be read as the current state of the offer rather than as a guarantee.
Data, GDPR & hosting
A consolidated view of how PubMed.ai handles your data.
GDPR overview
There is no GDPR implementation to report, because there is no GDPR statement at all. The words GDPR and RGPD appear nowhere on the site. There is no privacy policy, no cookie notice, no legal notice, no data protection officer, no Article 27 representative and no privacy contact address. No legal basis for processing is stated, no right of access, rectification or erasure is described, no data processing agreement is offered, and no list of sub-processors is published. The site nevertheless collects personal data through its contact form, its newsletter and the email address used to deliver research reports. Network resolution places the domain behind Cloudflare (AS13335), but that is an outside observation, not a disclosure. None of this proves compliance or non-compliance: the publisher takes no position, which leaves an EU user with no documented point of contact.
Who owns the data?
PubMed.ai publishes neither terms of service nor a privacy policy, so no contractual clause states who owns what. Nineteen usual paths were probed (/terms, /terms-of-service, /user-agreement, /legal, /imprint and others), the full 69-URL sitemap was read and the Wayback archive was searched: no such document exists today, and none appears in the site's history. Nothing addresses ownership of user queries, of the generated reports, or of the personal data collected through the contact form, the newsletter sign-up and the email address used to deliver reports. This is an observation of absence, not a finding of compliance or non-compliance: the publisher makes no statement either way.
Reuse rights
With no terms of service and no privacy policy, the site sets no rule on reuse: nothing grants, licenses or restricts the use of the summaries, citations and reports it produces, and nothing states what the publisher may do with the material users submit. Only the observable behavior is documented. Search queries are sent to the engine; the email address supplied is used to deliver the generated report, which the site says arrives directly in your inbox; the contact form and the newsletter collect a name and an email. The site never mentions model training on user data, in either direction, and says nothing about cookies, trackers or analytics. In practice, reuse rights should be treated as undefined rather than as granted, and sensitive or identifying content should be kept out of queries.
Data retention & training
Hosting summary
No hosting information is published. There is no trust page, no security page and no privacy policy, so the jurisdiction in which queries, email addresses and generated reports are stored is simply not stated. The only element available is a network observation made on 18 August 2026: pubmed.ai resolves to 188.114.97.7, an address belonging to Cloudflare (AS13335). That address is anycast, which means it identifies a content delivery edge node rather than a data center location; it says nothing about where the data actually sits and must not be read as evidence of hosting in the United States. No hosting country and no region are declared, which is why both fields are left empty in this record. The site claims no certification such as SOC 2, ISO 27001 or HIPAA, and makes no statement about encryption in transit or at rest. An organization with a data residency requirement has nothing here to assess.
Things to keep in mind
Risks and trade-offs to weigh before adopting PubMed.ai.
- No terms of service and no privacy policy: nothing contractually frames your use of the tool, nor the processing of what you type into it
- No identifiable legal entity, no postal address and no named officer, so there is nobody designated to answer for the service if something goes wrong
- No GDPR mention, no Article 27 representative and no data processing agreement, while the report is delivered by email: you hand over an address with no confidentiality commitment in return
- AI-generated content: the site states it is intended for academic reference and informational purposes only and does not constitute medical advice, diagnosis or treatment. A fluent summary is not a substitute for reading the paper, and leaning on it dulls the critical reading a literature review is supposed to build
- The name can be mistaken for PubMed, the NCBI or the NIH; the site describes itself as an independent research platform analyzing peer-reviewed literature based on publicly available PubMed references, and it is not affiliated with them
- The domain was registered with NameCheap on 2 April 2024 while the first Wayback capture dates from 22 March 2022, which points to a previous holder: the platform's actual track record is shorter than the archive suggests
- Broken links, with /product, service.pubmed.ai and service.pubmed.ai/docs all returning 404 on 18 August 2026, suggest parts of the service, the API included, may be dormant
Setup & Integrations
Technical difficulty
Effectively none for the end user. There is nothing to install, no extension and no account: you open the search page, type a query and read the answer. An email address is required only to receive the generated research report. The one step that involves any work is the API: access must be requested through the contact form, after which integration is a standard REST job, with endpoints, authentication and Server-Sent Events streaming, which assumes a developer on hand. In short, no setup for readers, ordinary integration work for developers.
Deployment
Behind PubMed.ai
Social
Resources
All the official URLs gathered for verification and reference.
Frequently asked questions
What is PubMed.ai?
What does it cover?
Is PubMed.ai free?
How does the search actually work?
What is Deep Chat?
What does the research report contain?
Can I export my citations?
Is there an API?
Can I use it to support a clinical decision?
What does the site say about my personal data?
Should you pick PubMed.ai?
PubMed.ai does one thing and does it with a clear head: it turns a research question into a sourced tour of the open-access biomedical literature. Pairing MeSH alignment with domain-tuned language models is the right engineering choice for this corpus, and the fact that every Key Insight links back to its PubMed record is what separates it from a chatbot that merely sounds confident. The structured report, from Abstract to References and delivered as PDF and Word with an .xlsx reference list, is the real differentiator, and it costs nothing.
The counterweight is the publisher. There is no company name, no postal address and no named person, not even in the section headed "Meet the Team Behind PubMed.ai". There are no terms of service and no privacy policy, which means no stated rule on data ownership, retention, deletion or reuse, and no GDPR statement of any kind, on a service that asks for an email address in order to deliver its reports. A handful of broken links, from the Product menu item to service.pubmed.ai, point to a young site that is not closely maintained at the edges.
The verdict follows from that split. As an exploratory and teaching tool, PubMed.ai is genuinely useful and free, and the search page answers without an account, which makes it easy to test before trusting. As soon as personal data, patient-related work or an institutional compliance framework enters the picture, the documentary void stops being a detail and becomes the deciding factor. Treat the output as academic reference material, which is what the site itself says on every page, verify the underlying papers through the PubMed links provided, and hand over as little personal information as the task allows.
- Choosing a selection results in a full page refresh.
- Opens in a new window.